Thermo Fisher Scientific Introduces Innovative Personal Cell Imaging Platform at Eighth Annual Cambridge Healthtech Meeting
PITTSBURGH, Pa. – Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific CellInsight Personal Cell Imager, a breakthrough in high-content analysis and cellular imaging technology.
Over the past 10 years, high-content analysis has become an increasingly important research tool, leading to advances in the understanding of cellular function. The advantages of this tool have not been available to every cell biology researcher, however, because of the complexity of operating the technology, its cost and other factors.
The CellInsight™ Personal Cell Imager addresses each of these barriers to adoption, providing all the benefits of cellular imaging in one simple-to-use, low-cost platform. A straightforward and streamlined workflow enables simple two-click image acquisition, autofocus, scanning and analysis of a sample plate.
The system features a unique solid state illumination source, high-efficiency filters and a custom optical design to deliver high-quality imaging and virtually maintenance-free operation. The CellInsight Personal Cell Imager is ideally suited for high throughput. Typical plate scan times are less than four minutes for a 96-well plate, while a 1,536-well plate can be scanned in just over one hour for a three-color assay. Robot compatibility ensures walk-away operation.
The CellInsight platform features Thermo Scientific iDEV workflow software to eliminate assay development bottlenecks. This software brings sophisticated quantitative image analysis to cell biologists, using pre-built biologically relevant measurement tools that do not require programming or special knowledge. The often overwhelming task of analyzing multi-parameter cell data is simplified by the revolutionary new Thermo Scientific iView software, which provides intuitive, image-centric tools and seamless integration with the Thermo Scientific HCi informatics software for data management and mining.
The CellInsight personal cell imaging (PCI) platform provides the cell biology researcher with a simple-to-operate, low-cost, bench-top automated imaging capability. By uniting powerful optical hardware, quantitative image analysis, informatics and automation with a range of fluorescent probes, engineered cell lines and assay kits, cell biology researchers can investigate hundreds of cellular targets and advance their knowledge of cell function.
The CellInsight Personal Cell Imager will be demonstrated exclusively at booth #11 during the Cambridge Healthtech Institute High-Content Analysis Meeting, Jan. 11-14, 2011, in San Francisco. For more information, visit www.thermoscientific.com/cellinsight.
For more information about the entire Thermo Scientific range of products for high-content imaging, please visit booth #11at the Cambridge Healthtech Institute High-Content Analysis Meeting, call 1-800-432-4091 or visit www.thermoscientfic.com/hcs.
Thermo Scientific is part of Thermo Fisher Scientific, the world leader in serving science.
About Thermo Fisher Scientific Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of more than $10 billion, we have approximately 35,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications. Visit www.thermofisher.com

